Meta-analysis: Randomized controlled trials of clindamycin/aminoglycoside vs. β-lactam monotherapy for the treatment of intra-abdominal infections

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 5, 2007, Pages 537-556

  Falagas, M E ^a,b,c   Matthaiou, D K ^a   Karveli, E A ^a   Peppas, G ^a,b  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; CEFAMANDOLE; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; GENTAMICIN; LATAMOXEF; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; SULPERAZON; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN SULFATE;

ABDOMINAL INFECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESEARCH; DRUG SAFETY; HUMAN; INFORMATION RETRIEVAL; LOADING DRUG DOSE; MEDICAL INFORMATION; MEDLINE; META ANALYSIS; MONOTHERAPY; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMS; DIGESTIVE SYSTEM DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33846993678     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03240.x     Document Type: Article

References (73)

1. Swenson RM, Lorber B, Michaelson TC, Spaulding EH. The bacteriology of intra-abdominal infections. Arch Surg 1974; 109(3): 398-399.
2. Tabaqchali S. The pathophysiological role of small intestinal bacterial flora. Scand J Gastroenterol Suppl 1970; 6: Suppl139-163.
3. Mandal AK, Thadepalli H. Contribution of intestinal flora to surgical infections. J Natl Med Assoc 1988; 80(7): 765-768.
4. Clark CH. Bacterial sensitivity to the aminoglycosides. Mod Vet Pract 1977; 58(8): 675-678.
5. Kalser MH, Cohen R, Arteaga I, et al. Normal viral and bacterial flora of the human small and large intestine. N Engl J Med 1966; 274(10): 558-563.
6. Ristuccia AM, Cunha BA. The aminoglycosides. Med Clin North Am 1982; 66(1): 303-312.
7. Del Bene VE, Farrar WE Jr. Antimicrobial therapy of infections due to anaerobic bacteria. Semin Drug Treat 1972; 2(3): 295-312.
8. Frankel RI. Clindamycin-efficacy and toxicity. West J Med 1975a; 122(6): 526-530.
9. Modde H. [Microbiological, pharmacological and clinical principles of clindamycin therapy]. Schweiz Med Wochenschr 1971; 101(45): 1632-1633.
10. Tally FP, Gorbach SL. Therapy of mixed anaerobic-aerobic infections. Lessons from studies of intra-abdominal sepsis. Am J Med 1985; 78(6A): 145-153.
11. Abou-Zeid AA, Shehata YM. Gentamicins. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 1977; 132(2): 97-108.
12. Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 1976; 12(3): 166-200.
13. Kunin CM. Nephrotoxicity of antibiotics. JAMA 1967; 202(3): 204-208.
14. Lehnhardt E. [Ototoxicity of antibiotics]. HNO 1970; 18(4): 97-101.
15. Simon HJ. Streptomycin, kanamycin, neomycin and paromomycin. Pediatr Clin North Am 1968; 15(1): 73-83.
16. Powell LL, Wilson SE. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surg Infect (Larchmt ) 2000; 1(1): 57-63.
17. Calandra GB, Ricci FM, Wang C, Brown KR. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials. J Clin Pharmacol 1988a; 28(2): 120-127.
18. Lee N, Yuen KY, Kumana CR. Clinical role of beta-lactam/beta-lactamase inhibitor combinations. Drugs 2003; 63(14): 1511-1524.
19. Alvan G, Nord CE. Adverse effects of monobactams and carbapenems. Drug Saf 1995; 12(5): 305-313.
20. Johnson AH. Adverse effects of antibiotics. Semin Drug Treat 1972; 2(3): 331-349.
21. Westerman G, Corman A, Stelos P, Nodine JH. Adverse reactions to penicillin. JAMA 1966; 198(2): 173-174.
22. Khan KS, Daya S, Jadad A. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 1996; 156(6): 661-666.
23. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996; 12(2): 195-208.
24. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22(4): 719-748.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-188.
26. Condon RE, Walker AP, Sirinek KR, et al. Meropenem vs. tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial. Clin Infect Dis 1995a; 21(3): 544-550.
27. Fink MP. Antibiotic therapy of intra-abdominal sepsis in the elderly: experience with ticarcillin and clavulanic acid. Surg Gynecol Obstet 1991; 172(Suppl): 36-41.
28. Harding G, Vincelette J, Rachlis A, et al. A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections. J Antimicrob Chemother 1982a; 10(Suppl. C): 191-192.
29. Polk HC Jr, Fink MP, Laverdiere M, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group. Am Surg 1993a; 59(9): 598-605.
30. Poenaru D, De Santis M, Christou NV. Imipenem vs. tobramycin-antianaerobe antibiotic therapy in intra-abdominal infections. Can J Surg 1990a; 33(5): 415-422.
31. Solomkin JS, Dellinger EP, Christou NV, Busuttil RW. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 1990a; 212(5): 581-591.
32. Hackford AW, Tally FP, Reinhold RB, Barza M, Gorbach SL. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections. Arch Surg 1988a; 123(3): 322-326.
33. Busuttil RW, McGrattan MA, Freischlag J. A comparative study of cefamandole vs. gentamicin plus clindamycin in the treatment of documented or suspected bacterial peritonitis. Surg Gynecol Obstet 1984a; 158(1): 1-8.
34. Baird IM. Multicentered study of cefoperazone for treatment of intraabdominal infections and comparison of cefoperazone with cefamandole and clindamycin plus gentamicin for treatment of appendicitis and peritonitis. Rev Infect Dis 1983a; 5(Suppl 1): S165-S172.
35. Stone HH, Morris ES, Geheber CE, Kolb LD, Dunlop WE. Clinical comparison of cefotaxime with gentamicin plus clindamycin in the treatment of peritonitis and other soft-tissue infections. Rev Infect Dis 1982a; 4(Suppl): S439-S443.
36. Danziger LH, Creger RJ, Shwed JA, Stellato TA, Hau T. Randomized trial of imipenem-cilastatin vs. gentamicin plus clindamycin in the treatment of polymicrobial infections. Pharmacotherapy 1988; 8(6): 315-318.
37. Drusano GL, Warren JW, Saah AJ, et al. A prospective randomized controlled trial of cefoxitin vs. clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet 1982a; 154(5): 715-720.
38. Solomkin JS, Fant WK, Rivera JO, Alexander JW. Randomized trial of imipenem/cilastatin vs. gentamicin and clindamycin in mixed flora infections. Am J Med 1985a; 78(6A): 85-91.
39. Sweet RL, Ohm-Smith M, Landers DV, Robbie MO. Moxalactam vs. clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol 1985a; 1: 808-817.
40. Tally FP, McGowan K, Kellum JM, Gorbach SL, O'Donnell TF. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg 1981a; 193(3): 318-323.
41. Rambo WM, Del Bene VE, Burkey LG, Collins CD, Richmond DK. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections. Rev Infect Dis 1982a; 4(Suppl): S683-S687.
42. Wilson SE. Results of a randomized, multicenter trial of meropenem vs. clindamycin/tobramycin for the treatment of intra-abdominal infections. Clin Infect Dis 1997; 24(Suppl 2): S197-S206.
43. Berne TV, Yellin AE, Appleman MD, Heseltine PN, Gill MA. Meropenem vs. tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis. J Am Coll Surg 1996; 182(5): 403-407.
44. Dougherty SH, Sirinek KR, Schauer PR, et al. Ticarcillin/ clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients. Am Surg 1995; 61(4): 297-303.
45. Shyr YM, Lui WY, Su CH, Wang LS, Liu CY. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections. Zhonghua Yi Xue Za Zhi (Taipei) 1995; 56(2): 102-108.
46. Greenberg RN, Cayavec P, Danko LS, et al. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections. J Antimicrob Chemother 1994; 34(3): 391-401.
47. Hopkins JA, Wilson SE, Bobey DG. Adjunctive antimicrobial therapy for complicated appendicitis: bacterial over-kill by combination therapy. World J Surg 1994; 18(6): 933-938.
48. Results of the North American trial of piperacillin/tazobactam compared with clindamycin, gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group. Eur J Surg 1994; 573: Suppl61-66.
49. Eckhauser FE, Knol JA, Raper SE, Mulholland MW, Helzerman P. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study. Clin Ther 1992; 14(1): 97-109.
50. Sirinek KR, Levine BA. A randomized trial of ticarcillin and clavulanate vs. gentamicin and clindamycin in patients with complicated appendicitis. Surg Gynecol Obstet 1991; 172(Suppl): 30-35.
51. Jauregui LE, Appelbaum PC, Fabian TC, Hageage G, Strausbaugh L, Martin LF. A randomized clinical study of cefoperazone and sulbactam vs. gentamicin and clindamycin in the treatment of intra-abdominal infections. J Antimicrob Chemother 1990a; 25(3): 423-433.
52. Fink MP, Helsmoortel CM, Arous EJ, et al. Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infections. J Antimicrob Chemother 1989; 24(Suppl. B): 147-156.
53. Zissis NP, Mullick RN. Piperacillin vs gentamicin-clindamycin combination in intra-abdominal infections. J Chemother 1989; 4(Suppl): 818-819.
54. Poularas J, Giamarellou H, Vlachos G, et al. The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan vs. netilmicin plus clindamycin. Chemioterapia 1988; 7(4): 253-255.
55. Stellato TA, Danziger LH, Hau T, Gauderer MW, Ferron JL, Gordon N. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis. Arch Surg 1988; 123(6): 714-717.
56. Gonzenbach HR, Simmen HP, Amgwerd R. Imipenem (N-F-thienamycin) vs. netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections. Ann Surg 1987; 205(3): 271-275.
57. Sirinek KR, Levine BA. Antimicrobial management of surgically treated gangrenous or perforated appendicitis: comparison of cefoxitin and clindamycin-gentamicin. Clin Ther 1987; 9(4): 420-428.
58. Heseltine PN, Berne TV, Yellin AE, Gill MA, Appleman MD. The efficacy of cefoxitin vs. clindamycin/gentamicin in surgically treated stab wounds of the bowel. J Trauma. 1986; 26(3): 241-5.
59. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections. Rev Infect Dis 1986; 8(Suppl. 5): S583-S588.
60. Guerra JG, Casalino E, Palomino JC, et al. Imipenem/Cilastatin vs. Gentamicin/Clindamycin for the treatment of moderate to severe infections in hospitalized patients. Rev.Infect.Dis 1985; 7[Suppl. 3]: 463-470.
61. Malangoni MA, Condon RE, Spiegel CA. Treatment of intra-abdominal infections is appropriate with single agent or combination antibiotic therapy. Surgery 1985; 98: 648-654.
62. Yellin AE, Heseltine PN, Berne TV, et al. The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet 1985; 161(4): 303-307.
63. Harding GK, Nicolle LE, Haase DA, et al. Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections. Rev Infect Dis 1984; 6(Suppl. 1): S283-S292.
64. Imipenem/cilastatin vs. gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group. Lancet 1984; 1(8382): 868-871.
65. Stone HH, Mullins RJ, Strom PR, Bourneuf AA, Geheber CE. Ceftriaxone vs. combined gentamicin and clindamycin for polymicrobial surgical sepsis. Am J Surg 1984; 148(4A): 30-34.
66. Schentag JJ, Wels PB, Reitberg DP, Walczak P, Van Tyle JH, Lascola RJ. A randomized clinical trial of moxalactam alone vs. tobramycin plus clindamycin in abdominal sepsis. Ann Surg 1983; 198(1): 35-41.
67. Stone HH, Strom PR, Fabian TC, Dunlop WE. Third-generation cephalosporins for polymicrobial surgical sepsis. Arch Surg 1983a; 118(2): 193-200.
68. Berne TV, Yellin AW, Appleman MD, Heseltine PN. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin vs. cefamandole vs. cefoperazone. Am J Surg 1982a; 144(1): 8-13.
69. Stone HH, Geheber CE, Kolb LD, Dunlop WE. Clinical comparison of cefotaxime vs. the combination of gentamicin plus clindamycin in the treatment of peritonitis and similar polymicrobial soft-tissue surgical sepsis. Clin Ther 1981; 4(Suppl. A): 67-80.
70. Bailey JA, Virgo KS, DiPiro JT, Nathens AB, Sawyer RG, Mazuski JE. Aminoglycosides for intra-abdominal infection: equal to the challenge Surg Infect (Larchmt ) 2002; 3(4): 315-335.
71. Rovers JP, Ilersich AL, Einarson TR. Meta-analysis of parenteral clindamycin dosing regimens. Ann Pharmacother 1995; 29(9): 852-858.
72. Holzheimer RG, Dralle H. Antibiotic therapy in intra-abdominal infections-a review on randomised clinical trials. Eur J Med Res 2001; 6(7): 277-291.
73. Falagas ME, Gorbach SL. Clindamycin and metronidazole. Med Clin North Am 1995; 79(4): 845-867.